Urea

Urea

SCHEMBL7180010

CCCCCc1nccs1.NC(N)=O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.42
HRH2 P25021 1/20 0.40
HRH1 P35367 1/20 0.40
FDPS P14324 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PKM P14618 1/20 0.39
CTSK P43235 1/20 0.38
MEN1 O00255 1/20 0.38
GAPDH P04406 1/20 0.38
POLB P06746 1/20 0.38
ALOX15 P16050 1/20 0.38
NR4A1 P22736 1/20 0.38
APEX1 P27695 1/20 0.38
PTPN7 P35236 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL244221 0.89 PLA2G4A (0.41) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL3309122 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL4585309 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL28198434 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL4584723 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL4584005 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL4584899 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL4584664 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL28198474 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS
SCHEMBL4586393 0.88 PLA2G4A (0.43) PLA2G4AL3MBTL1HRH2HRH1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0928790-B1 Thiazole derivatives HOFFMANN LA ROCHE (CH) 2003-03-05 EP disclosed
US-6344562-B1 ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2002-02-05 US disclosed
US-20020010316-A1 Thiazole derivatives ALIG LEO (CH) 2002-01-24 US disclosed
US-6320054-B1 INHIBIT BINDING OF ADHESIVE PROTEINS TO THE SURFACE OF DIFFERENT TYPES F CELL AND ACCORDINGLY INFLUENCE CELL-CELL AND CELL-MATRIX INTERACTIONS. HOFFMAN-LA ROCHE INC. 2001-11-20 US disclosed
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US disclosed
EP-0928790-A1 Thiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010316-A1 Thiazole derivatives VCAM1, SOST, TGFB1 PLA2G4A 4395/4885L3MBTL1 1072/4885HRH2 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.